Hub : Traits :

Allergy

1248 significantly associated models · 287 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	2235672	2742491	2	1	1.1e-09	2.4e-10	1.0e-03	73	TNFRSF14
2	1	7686056	11137778	6	2	5.7e-14	1.9e-12	1.0e-01	94	KIF1B RERE
3	1	24372971	25768937	1	1	7.0e-10	2.2e-14	1.3e-08	44	CLIC4
4	1	26399230	26917014	2	1	8.3e-08	2.7e-07	1.0e+00	100	CD52
5	1	91271668	92681020	1	1	1.5e-07	4.4e-05	5.4e-01	98	CDC7
6	1	151313774	152712747	2	5	5.5e-21	4.3e-19	8.6e-01	100	LINGO4 S100A11
7	1	153024634	155138557	6	1	7.4e-13	8.6e-14	3.7e-04	77	IL6R
8	1	160452218	161885352	4	1	3.6e-09	1.7e-09	1.3e-01	94	PPOX
9	1	166702558	168182443	1	1	7.4e-20	1.3e-20	1.0e+00	100	CD247
10	1	172311679	173713130	2	1	1.4e-11	1.8e-11	1.0e+00	100	TNFSF4
11	2	27971195	29344127	1	1	7.8e-10	1.7e-07	1.8e-01	94	RP11-373D23.3
12	2	29976100	31563885	1	1	1.3e-07	1.9e-06	1.0e+00	100	LCLAT1
13	2	60466491	62107632	5	1	9.3e-10	1.1e-08	1.0e-07	13	KIAA1841
14	2	101994731	104027106	7	7	1.2e-84	2.4e-72	1.0e+00	100	IL18RAP IL1R1 IL1RL1 SLC9A2
15	2	197134790	200117777	6	1	2.3e-10	6.1e-11	7.8e-03	84	SF3B1
16	3	55969663	57412804	2	1	4.8e-08	3.6e-09	2.4e-02	85	FAM208A
17	4	38079294	39824758	5	2	3.5e-58	6.7e-60	4.4e-03	97	FAM114A1 TLR1
18	4	102852939	104627833	4	1	1.3e-09	6.4e-09	2.9e-01	97	NFKB1
19	4	122377715	124935698	3	4	8.0e-34	2.7e-30	1.0e+00	100	KIAA1109 SPATA5
20	5	34920257	36637217	4	2	5.9e-38	2.3e-40	1.0e+00	100	IL7R
21	5	108927715	111770880	6	9	2.0e-45	4.3e-60	NaN	NaN	CAMK4 SLC25A46 TMEM232 TSLP WDR36
22	5	130830617	132900729	15	7	3.2e-17	1.1e-18	NaN	NaN	C5orf56 KIF3A PDLIM4 SLC22A5
23	5	140298815	142230251	2	2	7.9e-12	3.8e-11	5.6e-01	99	AC008781.7 NDFIP1
24	5	176067604	177426530	2	1	3.6e-09	1.3e-08	2.3e-01	96	RGS14
25	6	25266147	26689223	2	1	5.5e-12	1.5e-12	1.9e-02	89	TRIM38
26	6	89941356	91704536	1	1	3.8e-14	2.7e-18	7.2e-06	74	BACH2
27	6	107328319	108840870	1	1	1.8e-07	7.3e-07	2.9e-02	80	SCML4
28	6	134905567	136516257	2	2	1.6e-09	1.1e-09	5.9e-02	90	AHI1
29	7	27623776	28468319	1	1	1.0e-09	1.4e-16	2.6e-08	55	JAZF1
30	7	76254810	77744459	1	1	2.2e-07	1.2e-09	8.9e-04	70	GSAP
31	9	4659111	7345375	5	5	1.4e-19	1.0e-36	3.1e-10	75	ERMP1 GLDC KIAA1432 RANBP6
32	9	122881960	124487495	5	1	6.8e-10	7.6e-10	1.0e+00	100	TRAF1
33	9	126321003	127872298	2	1	3.9e-11	8.8e-10	1.0e-02	82	NEK6
34	9	130884753	132281720	1	1	6.9e-08	7.7e-08	2.0e-01	94	ENDOG
35	9	135883620	137326408	2	1	2.8e-16	2.0e-18	1.9e-07	65	ABO
36	10	5238196	7317647	3	3	8.8e-10	4.7e-22	1.9e-14	37	IL2RA PRKCQ
37	10	103527782	105275242	8	1	1.7e-11	1.8e-10	5.4e-01	99	ACTR1A
38	11	36068766	36732916	1	1	9.4e-09	4.7e-10	2.0e-05	53	PRR5L
39	11	61338245	61884025	1	1	2.6e-07	2.1e-06	1.3e-01	90	FADS2
40	11	64669105	66456387	8	2	1.0e-10	7.0e-18	1.5e-01	97	DKFZp761E198 OVOL1
41	11	75204622	77536441	5	4	3.4e-42	3.2e-67	2.1e-17	76	LRRC32 RP11-111M22.3 WNT11
42	11	110721187	112491227	7	1	3.1e-17	6.7e-19	1.0e+00	100	SIK2
43	11	118341649	119751585	2	1	1.7e-08	3.4e-11	3.5e-07	41	NLRX1
44	12	50110317	50601155	1	1	9.5e-08	4.2e-08	3.6e-02	85	AQP5
45	12	52820944	53321436	1	1	7.4e-08	3.1e-06	5.7e-01	98	KRT1
46	12	55601472	58677299	13	3	1.8e-21	1.4e-27	2.3e-02	96	GPR182 STAT6 SUOX
47	12	120502726	122037099	1	1	1.5e-09	4.9e-10	5.9e-03	80	SPPL3
48	12	122713991	124591385	11	1	2.9e-11	5.2e-10	8.2e-01	100	MPHOSPH9
49	13	40440805	41928314	1	1	2.7e-18	5.9e-13	1.4e-02	88	FOXO1
50	13	99155113	100728229	1	2	1.1e-13	1.8e-12	7.4e-03	86	UBAC2
51	14	34820295	36440325	3	1	2.1e-08	3.7e-07	9.9e-02	90	KIAA0391
52	14	92733536	93401178	1	1	5.6e-08	5.9e-07	5.4e-03	69	RIN3
53	15	40778506	42749023	10	1	1.7e-12	2.7e-13	1.5e-03	81	NDUFAF1
54	15	66662107	68492262	3	2	3.6e-28	9.2e-35	5.1e-07	83	AAGAB SMAD3
55	15	90208219	91744509	2	1	4.3e-15	9.5e-13	2.7e-01	98	IQGAP1
56	16	10325245	12138068	6	7	8.2e-32	1.8e-41	NaN	NaN	CLEC16A DEXI RMI2 RP11-396B14.2 RP11-876N24.5
57	16	26526350	28065536	3	1	3.8e-10	3.2e-11	9.6e-11	5	CTD-3203P2.1
58	17	36710513	39502398	23	3	1.3e-30	3.0e-28	1.0e+00	100	CASC3 KRT222 ORMDL3
59	17	39993748	41393295	3	1	1.3e-08	2.0e-07	2.7e-02	82	RP11-400F19.8
60	17	42628193	43570226	4	1	2.9e-10	1.4e-10	6.7e-02	92	MGC57346
61	17	46668951	48347817	2	1	3.7e-14	4.7e-15	1.0e-02	89	ZNF652
62	18	19692435	21303692	1	1	4.8e-08	1.5e-07	4.7e-01	98	RBBP8
63	18	47706580	49306115	2	1	1.1e-08	3.1e-09	1.1e-01	93	SMAD4
64	18	51100222	52540420	1	1	5.7e-09	2.1e-09	2.2e-05	50	POLI
65	19	2538668	3078394	2	1	1.4e-07	9.0e-07	8.8e-01	100	ZNF554
66	19	16368528	16876099	1	1	2.6e-07	4.1e-07	3.9e-05	34	C19orf44
67	20	51935779	52456445	1	1	1.7e-09	2.8e-13	1.7e-07	49	ZNF217
68	20	61522825	62912463	9	1	1.6e-11	6.4e-11	2.4e-02	88	STMN3
69	21	39849553	41383143	2	1	3.1e-08	2.9e-08	4.7e-06	32	PSMG1
70	22	37063016	37586000	1	1	2.3e-07	1.9e-07	2.5e-01	95	CSF2RB
71	22	40789606	42917154	14	1	3.8e-11	9.0e-10	9.3e-01	100	PHF5A

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Allergy or Eczema	25.95	92	80	177.8	-0.99	2.1e-91	AAGAB ABO AC008781.7 ACTR1A AHI1 AQP5 BACH2 C5orf56 CAMK4 CASC3 CD247 CLEC16A CLIC4 CSF2RB CTD-3203P2.1 DEXI DKFZp761E198 ENDOG ERMP1 FAM114A1 FAM208A FOXO1 GLDC GPR182 GSAP IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IQGAP1 JAZF1 KIAA0391 KIAA1109 KIAA1432 KIAA1841 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 NFKB1 ORMDL3 OVOL1 PHF5A POLI PPOX PRKCQ PRR5L PSMG1 RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SF3B1 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFRSF14 TNFSF4 TRAF1 TSLP UBAC2 WDR36 WNT11 ZNF217 ZNF652
Hayfever, allergic rhinitis or eczema	24.05	94	75	166.7	-0.99	1.7e-102	AC008781.7 ACTR1A AHI1 AQP5 BACH2 C5orf56 CAMK4 CD247 CD52 CDC7 CLEC16A CLIC4 CSF2RB CTD-3203P2.1 DEXI DKFZp761E198 ENDOG ERMP1 FAM114A1 FAM208A FOXO1 GLDC GPR182 GSAP IL18RAP IL1R1 IL1RL1 IL2RA IL6R IL7R IQGAP1 JAZF1 KIAA0391 KIAA1109 KIAA1432 KIAA1841 KIF3A KRT222 LCLAT1 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 NFKB1 NLRX1 ORMDL3 OVOL1 PHF5A POLI PPOX PRKCQ PRR5L PSMG1 RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SF3B1 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFRSF14 TNFSF4 TRAF1 TRIM38 TSLP UBAC2 WDR36 WNT11 ZNF217 ZNF554 ZNF652
Asthma	19.72	65	47	104.4	-0.97	5.9e-51	AAGAB AHI1 BACH2 C5orf56 CASC3 CD247 CD52 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 NDFIP1 NDUFAF1 ORMDL3 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPPL3 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP UBAC2 WDR36 WNT11 ZNF652
Asthma (self-reported)	19.39	68	49	108.9	-0.97	2.8e-52	AAGAB AHI1 BACH2 C5orf56 CASC3 CD247 CD52 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 NDFIP1 NDUFAF1 NEK6 ORMDL3 OVOL1 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP UBAC2 WDR36 WNT11 ZNF652
Respiratory disease	18.96	72	48	106.7	-0.96	1.4e-51	AAGAB AC008781.7 AHI1 BACH2 C5orf56 CASC3 CD247 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FAM208A FOXO1 GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL2RA IL7R JAZF1 KIAA1109 KIAA1432 KIF1B KIF3A KRT222 LINGO4 LRRC32 MGC57346 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 ORMDL3 PDLIM4 PHF5A POLI PPOX PRKCQ PSMG1 RANBP6 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 S100A11 SCML4 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SPATA5 SPPL3 STAT6 STMN3 SUOX TLR1 TMEM232 TNFSF4 TRAF1 TSLP UBAC2 WDR36 ZNF217 ZNF652
Blood Eosinophil Count	16.67	68	61	135.6	-0.86	2.2e-25	AAGAB ABO AHI1 BACH2 C5orf56 CAMK4 CASC3 CD247 CD52 CDC7 CLIC4 CTD-3203P2.1 DEXI DKFZp761E198 ERMP1 FADS2 FAM114A1 FOXO1 GLDC GPR182 IL18RAP IL1R1 IL1RL1 IL2RA IL7R KIAA1109 KIAA1432 KIF1B KIF3A KRT1 KRT222 LCLAT1 LRRC32 MPHOSPH9 NDFIP1 NDUFAF1 NEK6 OVOL1 PDLIM4 PHF5A POLI PPOX PRKCQ RANBP6 RBBP8 RERE RGS14 RIN3 RMI2 RP11-111M22.3 RP11-396B14.2 RP11-876N24.5 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 SMAD4 SPATA5 SPPL3 STAT6 SUOX TNFRSF14 TRAF1 TSLP UBAC2 WDR36 ZNF652
Hayfever/allergic rhinitis (self-reported)	11.02	29	14	31.1	-0.99	1.3e-27	BACH2 CD247 DEXI FAM114A1 GLDC GPR182 IL18RAP IL1RL1 IL7R IQGAP1 KIAA1109 KRT222 LRRC32 ORMDL3 PPOX RANBP6 RP11-396B14.2 RP11-876N24.5 SLC25A46 SLC9A2 SMAD3 SPATA5 STAT6 SUOX TLR1 TMEM232 TNFSF4 TSLP WDR36
Medication: Ventolin 100micrograms inhaler	8.84	19	7	15.6	-0.96	1.8e-12	AAGAB AHI1 BACH2 CD247 FOXO1 GLDC IL18RAP IL1RL1 KIAA1109 LRRC32 NDFIP1 ORMDL3 SLC22A5 SLC9A2 SMAD3 STAT6 SUOX TLR1 ZNF652
Wheeze or whistling in the chest in last year	7.53	27	13	28.9	-0.98	5.2e-23	BACH2 CASC3 CD247 DEXI FADS2 GLDC GPR182 IL1RL1 KIAA1109 KIAA1432 LRRC32 ORMDL3 RERE RIN3 RMI2 RP11-396B14.2 RP11-876N24.5 SIK2 SLC22A5 SLC25A46 SLC9A2 SMAD3 STMN3 TSLP UBAC2 WDR36 ZNF652
Crohns Disease (2017)	5.15	17	11	24.4	-0.11	6.4e-01	C5orf56 IL1R1 KIAA0391 KIAA1109 KIAA1841 KIF3A LRRC32 NDFIP1 ORMDL3 PDLIM4 RP11-111M22.3 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3 TNFSF4
Irritable Bowel Disease (IBD)	4.97	19	13	28.9	-0.35	9.9e-02	BACH2 C5orf56 IL1R1 KIAA0391 KIAA1109 KIAA1841 LINGO4 LRRC32 NDFIP1 ORMDL3 PDLIM4 RGS14 RMI2 RP11-111M22.3 RP11-373D23.3 SLC22A5 SMAD3 STMN3 TNFRSF14
Crohns Disease (2012)	4.08	10	6	13.3	-0.02	9.4e-01	C5orf56 LRRC32 NDFIP1 ORMDL3 PDLIM4 RP11-373D23.3 SF3B1 SLC22A5 SMAD3 STMN3
Medication: Seretide 50 evohaler	4.08	4	0	0.0	-0.93	8.0e-03	IL1RL1 SLC22A5 SMAD3 ZNF652
Number of self-reported non-cancer illnesses	3.92	10	3	6.7	-0.91	4.1e-05	AAGAB IL1RL1 LINGO4 LRRC32 ORMDL3 RGS14 RP11-396B14.2 RP11-876N24.5 SLC22A5 ZNF652
Blood White Count	3.77	35	22	48.9	-0.33	3.5e-02	ABO ACTR1A AHI1 BACH2 C19orf44 C5orf56 CASC3 CDC7 DEXI FADS2 GSAP IL1RL1 IQGAP1 KIAA1841 KIF3A MGC57346 NDFIP1 ORMDL3 PDLIM4 POLI PPOX RERE RGS14 RIN3 RP11-373D23.3 RP11-396B14.2 RP11-400F19.8 RP11-876N24.5 SCML4 SLC22A5 SPPL3 STMN3 TRAF1 ZNF217 ZNF652
Ulcerative Colitis (UC)	3.18	13	6	13.3	-0.50	5.9e-02	CASC3 IL1R1 KIAA1109 KIAA1841 KRT222 LRRC32 ORMDL3 PDLIM4 RGS14 SLC22A5 SMAD3 STMN3 TNFRSF14
Taking other prescription medications	3.07	3	3	6.7	-0.91	9.5e-02	IL1RL1 ORMDL3 ZNF652
Ulcerative Colitis	2.92	8	3	6.7	0.04	9.3e-01	ACTR1A IL1R1 KIAA1109 KIAA1841 ORMDL3 SLC22A5 STMN3 TNFRSF14
Blood clot in the leg (DVT)	2.77	1	1	2.2	0.00	1.0e+00	ABO
Deep venous thrombosis (DVT) (self-reported)	2.76	1	1	2.2	0.00	1.0e+00	ABO
Primary Biliary Cirrhosis	2.58	5	5	11.1	0.86	6.5e-02	DEXI IL7R NFKB1 ORMDL3 RMI2
Hypothyroidism (self reported)	2.52	14	5	11.1	-0.03	9.2e-01	AHI1 BACH2 CD247 ENDOG FADS2 IL7R KIAA1109 NEK6 RERE SPPL3 SUOX TLR1 TRAF1 UBAC2
Hypothyroidism/myxoedema (self-reported)	2.32	8	3	6.7	0.35	3.9e-01	AHI1 BACH2 CD247 FADS2 KIAA1109 NEK6 RERE SUOX
Lung FEV1/FVC ratio	2.20	22	12	26.7	0.84	1.4e-07	ABO AQP5 BACH2 FOXO1 GLDC IL1R1 IL1RL1 IL7R KIAA1432 ORMDL3 PDLIM4 PRKCQ RBBP8 RERE RGS14 RP11-396B14.2 SLC22A5 SLC9A2 SMAD3 STAT6 SUOX ZNF652
Medication: Levothyroxine sodium	2.16	5	2	4.4	0.75	1.4e-01	AHI1 BACH2 FADS2 IL7R SUOX
Number of treatments/medications taken	2.12	3	1	2.2	0.00	1.0e+00	NDUFAF1 SLC9A2 ZNF652
Rheumatoid Arthritis	1.96	1	0	0.0	0.00	1.0e+00	FADS2
Blood Platelet Count	1.81	26	26	57.8	-0.24	2.3e-01	ACTR1A C5orf56 CD52 CDC7 CLIC4 FADS2 FAM208A FOXO1 IL6R KIF1B KIF3A MPHOSPH9 NDFIP1 NLRX1 ORMDL3 OVOL1 PDLIM4 PHF5A PSMG1 SF3B1 SIK2 SLC22A5 SPPL3 STMN3 TRAF1 ZNF554
Impedance of arm (left)	1.77	14	9	20.0	-0.45	1.1e-01	ABO DEXI KIF1B LCLAT1 LRRC32 NEK6 NLRX1 OVOL1 PHF5A RIN3 RP11-373D23.3 SF3B1 SUOX ZNF652
Hair/balding pattern: Pattern 4	1.77	5	3	6.7	0.13	8.3e-01	CLIC4 IQGAP1 KIF1B MGC57346 S100A11
Impedance of arm (right)	1.76	17	9	20.0	-0.53	2.8e-02	AAGAB ABO ERMP1 KIF1B LCLAT1 LRRC32 NEK6 NLRX1 ORMDL3 OVOL1 PHF5A RIN3 RP11-373D23.3 SF3B1 SUOX TNFRSF14 ZNF652
Number of operations (self-reported)	1.76	1	0	0.0	0.00	1.0e+00	DEXI
Mouth/teeth dental problems: Mouth ulcers	1.75	1	0	0.0	0.00	1.0e+00	NFKB1
Breast Cancer	1.72	9	5	11.1	-0.64	6.5e-02	C5orf56 CDC7 DKFZp761E198 FAM114A1 KIF1B OVOL1 RP11-400F19.8 SLC22A5 TLR1
Long-standing illness, disability or infirmity	1.71	1	0	0.0	0.00	1.0e+00	ZNF652
Vascular/heart problems diagnosed by doctor	1.63	8	4	8.9	0.30	4.3e-01	AAGAB ABO NDUFAF1 RERE SIK2 SLC22A5 SUOX ZNF652
Hypertension (Self-reported)	1.60	10	4	8.9	-0.01	9.7e-01	ABO CLIC4 NDUFAF1 PDLIM4 POLI RERE SIK2 SLC22A5 SUOX ZNF652
Diastolic blood pressure, automated reading	1.60	9	5	11.1	-0.29	4.6e-01	AAGAB ABO CLIC4 MPHOSPH9 NDUFAF1 RERE STMN3 SUOX ZNF652
Lupus	1.56	2	0	0.0	0.00	1.0e+00	DEXI ORMDL3
High blood pressure	1.56	9	4	8.9	-0.07	8.6e-01	AAGAB ABO NDUFAF1 POLI RERE SIK2 SLC22A5 SUOX ZNF652
Headache pain in last month	1.55	2	1	2.2	0.00	1.0e+00	STAT6 SUOX
Medication: Blood pressure	1.52	2	2	4.4	0.00	1.0e+00	SIK2 ZNF652
Migraine (self-reported)	1.52	1	1	2.2	0.00	1.0e+00	STAT6
Father's age at death	1.51	2	0	0.0	0.00	1.0e+00	ABO SLC22A5
Lung FVC	1.50	13	10	22.2	0.19	5.1e-01	AAGAB ABO AHI1 C5orf56 KIF1B LINGO4 MPHOSPH9 RBBP8 RIN3 SLC22A5 SPPL3 STMN3 SUOX
Cardiovascular Disease	1.47	11	4	8.9	-0.19	5.8e-01	AAGAB C5orf56 CLIC4 KRT222 NDUFAF1 RERE RP11-111M22.3 SIK2 SLC22A5 SUOX ZNF652
Type 2 Diabetes (T2D) (2012)	1.45	1	0	0.0	0.00	1.0e+00	JAZF1
Impedance of whole body	1.45	12	7	15.6	-0.44	1.5e-01	DEXI ERMP1 KIF1B LRRC32 NEK6 PHF5A RIN3 RP11-400F19.8 SF3B1 SUOX TNFRSF14 ZNF652
Standing height	1.43	22	18	40.0	0.46	2.4e-02	AAGAB ACTR1A C5orf56 CD52 DKFZp761E198 FADS2 FAM208A IL1R1 IQGAP1 MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 PHF5A RBBP8 RGS14 RP11-373D23.3 SLC22A5 SPPL3 STAT6 TRIM38 ZNF652
Gout (self-reported)	1.42	1	0	0.0	0.00	1.0e+00	OVOL1
Medication: Blood pressure	1.41	3	0	0.0	0.00	1.0e+00	NDUFAF1 SIK2 SLC22A5
Medication: Metformin	1.40	1	0	0.0	0.00	1.0e+00	ABO
Trunk predicted mass	1.40	16	12	26.7	0.55	2.6e-02	ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Arm predicted mass (right)	1.40	14	11	24.4	0.51	6.4e-02	ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Chest pain or discomfort	1.40	1	0	0.0	0.00	1.0e+00	IL1RL1
Arm predicted mass (left)	1.40	14	10	22.2	0.50	6.6e-02	ABO ACTR1A FAM208A FOXO1 MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Trunk fat-free mass	1.39	16	12	26.7	0.55	2.6e-02	ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Vitamin and mineral supplements	1.38	1	1	2.2	0.00	1.0e+00	STAT6
Age when periods started (menarche)	1.38	4	1	2.2	-0.65	3.5e-01	PDLIM4 PSMG1 SPPL3 SUOX
Arm fat-free mass (right)	1.38	14	10	22.2	0.51	6.1e-02	ABO ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Arm fat-free mass (left)	1.38	13	10	22.2	0.47	1.0e-01	ABO ACTR1A FAM208A MPHOSPH9 NEK6 NLRX1 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 SUOX TRIM38
Prostate Cancer	1.37	2	0	0.0	0.00	1.0e+00	ACTR1A IL6R
LDL Cholesterol	1.37	2	2	4.4	0.00	1.0e+00	ABO FADS2
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.37	2	0	0.0	0.00	1.0e+00	ORMDL3 STMN3
Blood Red Count	1.36	20	15	33.3	0.26	2.5e-01	ABO AHI1 BACH2 CLIC4 CSF2RB FADS2 FAM114A1 FAM208A FOXO1 LINGO4 MGC57346 NDFIP1 NDUFAF1 NFKB1 POLI RGS14 SF3B1 SUOX TLR1 ZNF217
Smoking Status	1.36	5	3	6.7	0.18	7.7e-01	ACTR1A PHF5A RERE SUOX ZNF652
Past tobacco smoking	1.35	3	1	2.2	0.00	1.0e+00	AAGAB ACTR1A PSMG1
Medication for cholesterol, blood pressure or diabetes	1.35	3	1	2.2	0.00	1.0e+00	NDUFAF1 SIK2 ZNF652
Knee pain experienced in last month	1.35	1	0	0.0	0.00	1.0e+00	RP11-396B14.2
Ever had bowel cancer screening	1.35	1	0	0.0	0.00	1.0e+00	SIK2
Hand grip strength (right)	1.34	6	3	6.7	0.79	1.9e-02	ACTR1A C5orf56 IL1R1 KIF1B PDLIM4 SLC22A5
Mouth/teeth dental problems: Dentures	1.34	2	0	0.0	0.00	1.0e+00	C5orf56 PPOX
Medication: Paracetamol	1.34	1	1	2.2	0.00	1.0e+00	STAT6
Medication for pain relief, constipation, heartburn	1.33	2	1	2.2	0.00	1.0e+00	MPHOSPH9 STAT6
Medication: Allopurinol	1.32	1	0	0.0	0.00	1.0e+00	OVOL1
Illnesses of father: Heart disease	1.32	2	0	0.0	0.00	1.0e+00	ABO SIK2
Coronary Artery Disease (CAD)	1.31	1	0	0.0	0.00	1.0e+00	ABO
HDL Cholesterol	1.31	2	2	4.4	0.00	1.0e+00	FADS2 ORMDL3
Medication: Aspirin	1.31	1	0	0.0	0.00	1.0e+00	SIK2
Ever smoked	1.31	2	0	0.0	0.00	1.0e+00	ACTR1A PSMG1
Height	1.30	28	22	48.9	0.42	1.9e-02	AAGAB ABO ACTR1A C5orf56 CD52 DKFZp761E198 FADS2 FAM208A IL18RAP IL1R1 IQGAP1 KIAA1109 KIF1B KIF3A MPHOSPH9 NDUFAF1 NFKB1 PDLIM4 PHF5A RBBP8 RERE RGS14 RP11-373D23.3 SLC22A5 SPPL3 STAT6 ZNF554 ZNF652
Severe depression (siblings)	1.29	1	0	0.0	0.00	1.0e+00	IL18RAP
Had major operations	1.29	1	0	0.0	0.00	1.0e+00	ZNF652
Whole body water mass	1.29	14	10	22.2	0.61	2.1e-02	ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NLRX1 PDLIM4 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Birth weight of first child	1.28	1	0	0.0	0.00	1.0e+00	SUOX
Whole body fat-free mass	1.28	15	10	22.2	0.63	1.2e-02	ACTR1A DKFZp761E198 FAM208A MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 RBBP8 RIN3 RP11-373D23.3 SF3B1 SLC22A5 STAT6 SUOX TRIM38
Multivitamins +/- minerals	1.27	1	0	0.0	0.00	1.0e+00	STAT6
Hair/balding pattern: Pattern 2	1.27	1	0	0.0	0.00	1.0e+00	CLIC4
Medication: Ibuprofen (e.g. Nurofen)	1.27	1	1	2.2	0.00	1.0e+00	STAT6
Alcohol drinker status: Never	1.27	1	0	0.0	0.00	1.0e+00	SLC9A2
Birth weight	1.26	3	0	0.0	0.00	1.0e+00	NFKB1 SIK2 TRAF1
Medication: Atorvastatin	1.26	1	0	0.0	0.00	1.0e+00	ABO
Triglycerides	1.25	2	2	4.4	0.00	1.0e+00	FADS2 RP11-373D23.3
Current tobacco smoking	1.25	2	1	2.2	0.00	1.0e+00	PHF5A STMN3
Breastfed as a baby	1.25	1	0	0.0	0.00	1.0e+00	MPHOSPH9
Sitting height	1.24	14	8	17.8	0.60	1.8e-02	ACTR1A CD52 FAM114A1 FAM208A KIAA1109 MPHOSPH9 NDUFAF1 NLRX1 PDLIM4 RGS14 SLC22A5 STAT6 TRIM38 ZNF652
Forced expiratory volume in 1-second (FEV1), predicted	1.24	2	1	2.2	0.00	1.0e+00	ACTR1A SLC22A5
Hand grip strength (left)	1.23	5	3	6.7	0.99	6.3e-04	ACTR1A C5orf56 KIF1B PDLIM4 SLC22A5
Forced expiratory volume in 1-second (FEV1), Best measure	1.23	4	0	0.0	1.00	1.9e-03	ABO SLC22A5 STMN3 SUOX
Smoking status: Current	1.23	1	1	2.2	0.00	1.0e+00	PHF5A
Heel T-Score	1.22	14	11	24.4	0.08	8.0e-01	AAGAB ABO ERMP1 FADS2 FAM208A IQGAP1 KIF1B LCLAT1 MPHOSPH9 NEK6 OVOL1 RERE RIN3 ZNF554
Number of live births	1.22	1	0	0.0	0.00	1.0e+00	NFKB1
Pulse rate, automated reading	1.22	4	1	2.2	0.44	5.6e-01	ABO FADS2 SIK2 SUOX
Shortness of breath walking on level ground	1.21	1	0	0.0	0.00	1.0e+00	LRRC32
Basal metabolic rate	1.21	15	8	17.8	0.63	1.3e-02	ACTR1A DKFZp761E198 FAM208A FOXO1 MPHOSPH9 NLRX1 RBBP8 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Fractured/broken bones in last 5 years	1.21	1	0	0.0	0.00	1.0e+00	AAGAB
Pain experienced in last month	1.21	2	1	2.2	0.00	1.0e+00	STAT6 SUOX
Chronotype (morning person)	1.20	2	0	0.0	0.00	1.0e+00	KIAA1109 SF3B1
Ever used hormone-replacement therapy (HRT)	1.20	1	0	0.0	0.00	1.0e+00	NEK6
Alcohol intake frequency.	1.20	3	0	0.0	0.00	1.0e+00	NFKB1 STAT6 SUOX
Comparative height size at age 10	1.20	11	8	17.8	0.64	2.6e-02	AAGAB ACTR1A C5orf56 DKFZp761E198 IQGAP1 MPHOSPH9 NLRX1 PDLIM4 RBBP8 SLC22A5 TRIM38
Diabetes diagnosed by doctor	1.20	1	0	0.0	0.00	1.0e+00	JAZF1
Medication: Simvastatin	1.19	2	0	0.0	0.00	1.0e+00	ABO NDUFAF1
Depression (Nagel 2018)	1.18	1	1	2.2	0.00	1.0e+00	RERE
Impedance of leg (right)	1.18	7	4	8.9	-0.59	1.6e-01	AQP5 RIN3 RP11-400F19.8 SF3B1 SUOX TNFRSF14 ZNF652
Comparative body size at age 10	1.18	2	1	2.2	0.00	1.0e+00	OVOL1 ZNF652
Medication: Ibuprofen	1.18	1	1	2.2	0.00	1.0e+00	STAT6
Myopia	1.17	1	0	0.0	0.00	1.0e+00	STAT6
Heart attack/myocardial infarction (self-reported)	1.17	1	0	0.0	0.00	1.0e+00	ZNF652
Cholesterol lowering medication	1.16	1	1	2.2	0.00	1.0e+00	ABO
Impedance of leg (left)	1.15	7	4	8.9	-0.54	2.1e-01	RIN3 RP11-400F19.8 S100A11 SF3B1 SUOX TNFRSF14 ZNF652
Heel bone mineral density (BMD) T-score, automated (right)	1.15	3	2	4.4	0.00	1.0e+00	FADS2 IQGAP1 RERE
Forced expiratory volume in 1-second (FEV1)	1.15	5	0	0.0	0.99	1.7e-03	ABO AHI1 LINGO4 STMN3 SUOX
Medication: Paracetamol	1.15	1	1	2.2	0.00	1.0e+00	STAT6
Leg fat percentage (right)	1.14	6	3	6.7	0.25	6.3e-01	AAGAB FADS2 KRT222 RERE RP11-400F19.8 TRIM38
Fluid intelligence score	1.13	2	0	0.0	0.00	1.0e+00	MPHOSPH9 SUOX
Age at first live birth	1.13	1	0	0.0	0.00	1.0e+00	SUOX
Leg fat percentage (left)	1.13	6	2	4.4	-0.01	9.9e-01	AAGAB KRT222 MPHOSPH9 RERE RP11-400F19.8 TRIM38
Frequency of depressed mood in last 2 weeks	1.12	1	0	0.0	0.00	1.0e+00	RERE
Trunk fat percentage	1.12	8	5	11.1	-0.27	5.1e-01	AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 SF3B1 TRIM38
Neck or shoulder pain in last month	1.12	1	0	0.0	0.00	1.0e+00	SUOX
Leg predicted mass (right)	1.12	13	7	15.6	0.72	5.9e-03	ACTR1A FAM208A MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Leg predicted mass (left)	1.11	14	7	15.6	0.72	3.8e-03	ACTR1A FAM208A FOXO1 MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Heart attack	1.11	1	0	0.0	0.00	1.0e+00	ZNF652
Body fat percentage	1.11	7	3	6.7	-0.18	7.0e-01	AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 TRIM38
Leg fat-free mass (right)	1.11	13	7	15.6	0.71	6.1e-03	ACTR1A FAM208A MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SF3B1 SLC22A5 SUOX TNFRSF14 TRIM38
Reaction Time	1.10	1	0	0.0	0.00	1.0e+00	ACTR1A
Schizophrenia (2014)	1.10	4	1	2.2	-0.44	5.6e-01	MPHOSPH9 RERE SF3B1 STAT6
Leg fat-free mass (left)	1.10	13	7	15.6	0.71	6.9e-03	ACTR1A FAM208A FOXO1 MPHOSPH9 NLRX1 PDLIM4 RIN3 RP11-373D23.3 RP11-400F19.8 SLC22A5 SUOX TNFRSF14 TRIM38
Qualifications: None of the above	1.10	3	2	4.4	0.00	1.0e+00	FAM208A MPHOSPH9 SUOX
Angina	1.09	1	1	2.2	0.00	1.0e+00	ZNF652
Depression (self-reported)	1.09	1	0	0.0	0.00	1.0e+00	RERE
Qualifications: College or University degree	1.09	3	2	4.4	0.00	1.0e+00	MPHOSPH9 SUOX TRIM38
High cholesterol (Self-reported)	1.09	1	1	2.2	0.00	1.0e+00	ABO
Bipolar Disorder or Schizophrenia	1.08	2	1	2.2	0.00	1.0e+00	SF3B1 STAT6
Waist Hip Ratio (WHR)	1.08	10	3	6.7	0.28	4.1e-01	AAGAB CLEC16A ENDOG GSAP MPHOSPH9 RBBP8 RP11-396B14.2 RP11-876N24.5 SF3B1 SIK2
Relative age voice broke	1.08	1	0	0.0	0.00	1.0e+00	PSMG1
Type 2 Diabetes (T2D) (2018)	1.07	1	0	0.0	0.00	1.0e+00	JAZF1
Hearing difficulty/problems with background noise	1.07	1	0	0.0	0.00	1.0e+00	ACTR1A
Pulse rate	1.07	1	0	0.0	0.00	1.0e+00	FADS2
Schizophrenia (2018)	1.06	3	0	0.0	0.00	1.0e+00	RERE SF3B1 STAT6
Relative age of first facial hair	1.06	2	1	2.2	0.00	1.0e+00	PSMG1 SPPL3
Heel bone mineral density (BMD) T-score, automated (left)	1.06	2	2	4.4	0.00	1.0e+00	IQGAP1 RERE
Peak expiratory flow (PEF)	1.05	2	1	2.2	0.00	1.0e+00	ABO ACTR1A
Forced vital capacity (FVC)	1.04	5	3	6.7	0.69	8.5e-02	AAGAB ACTR1A AHI1 LINGO4 STMN3
Weight	1.03	11	6	13.3	0.54	8.3e-02	AAGAB ACTR1A FAM208A FOXO1 NLRX1 RP11-373D23.3 RP11-400F19.8 SLC22A5 SUOX TNFRSF14 TRIM38
Qualifications: O levels/GCSEs or equivalent	1.03	1	1	2.2	0.00	1.0e+00	MPHOSPH9
Qualifications: nursing, teaching	1.03	1	0	0.0	0.00	1.0e+00	MPHOSPH9
Supplements: Vitamin C	1.02	1	0	0.0	0.00	1.0e+00	ORMDL3
Arm fat percentage (right)	1.01	7	3	6.7	-0.01	9.8e-01	AAGAB ABO RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Qualifications: A levels/AS levels or equivalent	1.01	2	1	2.2	0.00	1.0e+00	MPHOSPH9 SUOX
Angina (self-reported)	1.01	1	0	0.0	0.00	1.0e+00	ZNF652
Overall health rating	1.01	2	1	2.2	0.00	1.0e+00	SF3B1 ZNF652
Arm fat percentage (left)	1.01	8	4	8.9	-0.12	7.7e-01	AAGAB ABO PHF5A PSMG1 RERE RP11-400F19.8 TNFRSF14 TRIM38
Systolic Blood Pressure	1.00	9	7	15.6	-0.59	7.3e-02	CLIC4 FAM208A MGC57346 NDUFAF1 RERE RP11-111M22.3 RP11-373D23.3 SIK2 ZNF652
Waist circumference	1.00	7	3	6.7	0.75	5.2e-02	AAGAB FOXO1 RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Leg fat mass (right)	1.00	9	3	6.7	0.34	3.7e-01	AAGAB NLRX1 PSMG1 RERE RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Major Depression (MDD)	0.99	1	0	0.0	0.00	1.0e+00	IL6R
Trunk fat mass	0.99	6	2	4.4	-0.01	9.9e-01	AAGAB PHF5A RERE RP11-400F19.8 TNFRSF14 TRIM38
Hair/balding pattern: Pattern 3	0.99	1	0	0.0	0.00	1.0e+00	CLIC4
Tense / 'highly strung'	0.99	1	1	2.2	0.00	1.0e+00	RERE
Forced vital capacity (FVC), Best measure	0.99	5	2	4.4	0.70	1.2e-01	AAGAB ACTR1A AHI1 LINGO4 STMN3
Whole body fat mass	0.99	9	3	6.7	0.08	8.4e-01	AAGAB NLRX1 PHF5A PSMG1 RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Leg fat mass (left)	0.99	9	3	6.7	0.35	3.6e-01	AAGAB NLRX1 PSMG1 RERE RP11-373D23.3 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Alzheimer’s Disease (including proxy)	0.98	1	0	0.0	0.00	1.0e+00	PPOX
Systolic blood pressure, automated reading	0.98	3	2	4.4	0.00	1.0e+00	MGC57346 NDUFAF1 RERE
Medication: Cholesterol lowering	0.98	2	0	0.0	0.00	1.0e+00	ABO NDUFAF1
Worry too long after embarrassment	0.98	1	0	0.0	0.00	1.0e+00	AHI1
Suffer from 'nerves'	0.98	1	0	0.0	0.00	1.0e+00	RERE
Depressed Affect (Nagel 2018)	0.97	2	0	0.0	0.00	1.0e+00	PHF5A RERE
Neuroticism (Nagel 2018)	0.95	2	1	2.2	0.00	1.0e+00	PHF5A RERE
Body mass index (BMI)	0.95	5	4	8.9	0.99	1.0e-03	PSMG1 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Arm fat mass (left)	0.95	9	5	11.1	0.41	2.8e-01	AAGAB FOXO1 NLRX1 PSMG1 RERE RP11-400F19.8 SUOX TNFRSF14 TRIM38
Hip circumference	0.94	6	1	2.2	0.68	1.4e-01	FOXO1 NLRX1 PSMG1 RP11-373D23.3 SUOX TRIM38
Intelligence (Savage-Jansen 2018)	0.93	4	1	2.2	-0.07	9.3e-01	IL18RAP MPHOSPH9 PSMG1 SUOX
Verbal and Numeric Reasoning (VNR)	0.93	1	0	0.0	0.00	1.0e+00	SUOX
Arm fat mass (right)	0.93	8	4	8.9	0.64	8.8e-02	AAGAB FOXO1 NLRX1 PSMG1 RP11-400F19.8 SUOX TNFRSF14 TRIM38
Loneliness, isolation	0.90	1	0	0.0	0.00	1.0e+00	RERE
Mood swings	0.87	1	0	0.0	0.00	1.0e+00	PHF5A
BMI	0.86	7	4	8.9	0.57	1.8e-01	AAGAB NEK6 PSMG1 RP11-400F19.8 SUOX TLR1 TNFRSF14
Unable to work because of sickness or disability	0.86	1	0	0.0	0.00	1.0e+00	SF3B1
Worrier / anxious feelings	0.82	1	0	0.0	0.00	1.0e+00	ACTR1A
Neuroticism	0.80	2	1	2.2	0.00	1.0e+00	AAGAB RERE
Neuroticism score	0.77	2	0	0.0	0.00	1.0e+00	PHF5A RERE
Tanning	0.20	1	0	0.0	0.00	1.0e+00	RP11-373D23.3
Hair Pigment	0.19	8	6	13.3	-0.42	2.6e-01	AHI1 FADS2 JAZF1 KIAA1432 KIF1B MPHOSPH9 RP11-373D23.3 SUOX

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	16	0.96	2.6
The Cancer Genome Atlas	Testicular Germ Cell Tumors	18	1.41	2.6
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	5	0.98	2.6
GTEx	Breast Mammary Tissue	21	1.06	2.5
GTEx	Breast Mammary Tissue (Male)	9	0.75	2.5
GTEx	Pancreas	16	0.98	2.5
GTEx	Whole Blood	18	0.90	2.5
NTR	Blood	22	0.92	2.5
YFS	Blood	43	0.93	2.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	16	0.78	2.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	28	1.12	2.5
The Cancer Genome Atlas	Stomach Adenocarcinoma	20	1.19	2.5
GTEx	Brain Cortex	7	0.68	2.4
GTEx	Brain Nucleus accumbens basal ganglia	11	1.27	2.4
GTEx	Breast Mammary Tissue (Female)	16	0.97	2.4
GTEx	Cells Transformed fibroblasts	39	0.93	2.4
GTEx	Colon Transverse	20	0.97	2.4
GTEx	Esophagus Mucosa	27	0.81	2.4
GTEx	Skin Not Sun Exposed Suprapubic	28	1.14	2.4
GTEx	Spleen	13	0.92	2.4
GTEx	Testis	28	0.89	2.4
GTEx	Thyroid	34	0.85	2.4
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	14	0.85	2.4
The Cancer Genome Atlas	Colon Adenocarcinoma	19	0.92	2.4
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	23	0.84	2.4
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	30	0.73	2.4
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	7	0.63	2.4
The Cancer Genome Atlas	Lung Adenocarcinoma	22	0.75	2.4
The Cancer Genome Atlas	Thyroid Carcinoma	42	0.81	2.4
GTEx	Adipose Visceral Omentum	18	0.88	2.3
GTEx	Artery Tibial	26	0.69	2.3
GTEx	Brain Cerebellar Hemisphere	10	0.67	2.3
GTEx	Brain Cerebellum	14	0.71	2.3
GTEx	Brain Frontal Cortex BA9	10	1.08	2.3
GTEx	Brain Hypothalamus	8	1.36	2.3
GTEx	Brain Putamen basal ganglia	7	1.12	2.3
GTEx	Colon Sigmoid	10	0.68	2.3
GTEx	Esophagus Gastroesophageal Junction	9	0.62	2.3
GTEx	Esophagus Muscularis	25	0.77	2.3
GTEx	Heart Atrial Appendage	9	0.57	2.3
GTEx	Skin Sun Exposed Lower leg	32	0.88	2.3
GTEx	Uterus	4	0.71	2.3
METSIM	Adipose	36	0.78	2.3
The Cancer Genome Atlas	Breast Invasive Carcinoma	37	0.84	2.3
The Cancer Genome Atlas	Glioblastoma Multiforme	9	0.88	2.3
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	13	0.82	2.3
The Cancer Genome Atlas	Rectum Adenocarcinoma	7	1.01	2.3
The Cancer Genome Atlas	Skin Cutaneous Melanoma	5	0.93	2.3
GTEx	Adipose Subcutaneous	21	0.60	2.2
GTEx	Artery Aorta	23	0.77	2.2
GTEx	Liver	5	0.70	2.2
GTEx	Lung	18	0.63	2.2
GTEx	Muscle Skeletal	19	0.66	2.2
GTEx	Nerve Tibial	29	0.67	2.2
GTEx	Ovary	7	0.77	2.2
GTEx	Pituitary	11	0.99	2.2
GTEx	Prostate	6	0.72	2.2
ROSMAP	Brain Pre-frontal Cortex	23	0.52	2.2
CommonMind	Brain Pre-frontal Cortex	41	0.76	2.2
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	7	0.64	2.2
The Cancer Genome Atlas	Esophageal Carcinoma	5	0.73	2.2
The Cancer Genome Atlas	Brain Lower Grade Glioma	27	0.63	2.2
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	6	0.45	2.2
The Cancer Genome Atlas	Prostate Adenocarcinoma	39	0.84	2.2
GTEx	Adrenal Gland	10	0.69	2.1
GTEx	Artery Coronary	4	0.34	2.1
GTEx	Small Intestine Terminal Ileum	1	0.22	2.1
GTEx	Stomach	12	0.83	2.1
GTEx	Vagina	4	0.63	2.1
The Cancer Genome Atlas	Soft Tissue Sarcoma	4	0.37	2.1
GTEx	Brain Caudate basal ganglia	5	0.54	2.0
GTEx	Cells EBV-transformed lymphocytes	9	0.63	2.0
GTEx	Brain Hippocampus	3	0.57	1.9
GTEx	Heart Left Ventricle	8	0.52	1.9